Univest
Univest
  • Markets
  • 3 Pain and Anti-Malarial Brands, Branded Generics Marketer and Global Generics and Specialty Franchise Stocks With a Strong Future Roadmap: Ipca Laboratories, Emcure Pharmaceuticals and Lupin

    • October 23, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Pain and Anti-Malarial Brands, Branded Generics Marketer and Global Generics and Specialty Franchise Stocks With a Strong Future Roadmap: Ipca Laboratories, Emcure Pharmaceuticals and Lupin

    Pain Care and Specialty Generics Stocks with a strong future roadmap: Ipca Laboratories, Emcure Pharmaceuticals and Lupin. Compare price, valuation, return on equity and revenue growth as of 22 October 2026.

    read more
  • 3 Oncology Generics, Acute Therapy Franchise and Pain and Anti-Malarial Brands Stocks With a Strong Future Roadmap: Natco Pharma, Alkem Laboratories and Ipca Laboratories

    • October 22, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Oncology Generics, Acute Therapy Franchise and Pain and Anti-Malarial Brands Stocks With a Strong Future Roadmap: Natco Pharma, Alkem Laboratories and Ipca Laboratories

    Complex Generic and Pain Care Stocks with a strong future roadmap: Natco Pharma, Alkem Laboratories and Ipca Laboratories. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Domestic Brands, Anti-Malarial Leader and Anti-Retroviral Ingredients Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Ipca Laboratories and Laurus Labs

    • October 22, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Domestic Brands, Anti-Malarial Leader and Anti-Retroviral Ingredients Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Ipca Laboratories and Laurus Labs

    Branded and API Pharma Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Ipca Laboratories and Laurus Labs. Compare price, valuation, return on equity and revenue growth as of 21 October 2026.

    read more
  • 3 Formulations and APIs, Chronic Therapy Brands and Fermentation Ingredients Stocks With a Strong Future Roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech

    • October 21, 2026
    • Posted by: Ankit Jaiswal
    • Category: Best Stocks
    No Comments
    3 Formulations and APIs, Chronic Therapy Brands and Fermentation Ingredients Stocks With a Strong Future Roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech

    Mid-cap Pharma Growth Stocks with a strong future roadmap: Ipca Laboratories, Eris Lifesciences and Concord Biotech. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.

    read more
  • 3 Cardiac Brands, Pain Care Portfolio and Custom Synthesis Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories

    • October 21, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Cardiac Brands, Pain Care Portfolio and Custom Synthesis Stocks With a Strong Future Roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi's Laboratories

    Pharma Brand and Ingredient Stocks with a strong future roadmap: Torrent Pharmaceuticals, Ipca Laboratories and Divi’s Laboratories. Compare price, valuation, return on equity and revenue growth as of 20 October 2026.

    read more
  • 1
  • 2